Collaboration models:


TargetRx has several pre-clinical and clinical stage programs with first-in-class or best-in-class potential. We are actively looking for global partners for out-licensing to maximize the value of our products while accelerating global clinical development and commercialization to bring better treatment options to patients worldwide.


TargetRx has full-chain R&D capabilities covering from early discovery to clinical development.We are open to join hands with partners to integrate each party's resources and expertise to develop novel programs in multiple aspects.

For more information about partnering with TargetRx, please contact us at